seed
Stage
1
Investors
About
Zora Biosciences develops clinical diagnostic tests based on lipid biomarkers using mass spectrometry to improve early detection and risk assessment of cardiometabolic diseases such as cardiovascular disease and type 2 diabetes.
Explore Zora Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.